HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Emile Voest Selected Research
Emile Voest Research Topics
Disease
17
Neoplasms (Cancer)
04/2024 - 09/2002
3
Breast Neoplasms (Breast Cancer)
01/2023 - 12/2007
3
Adenocarcinoma
01/2014 - 09/2002
1
Lung Neoplasms (Lung Cancer)
04/2024
1
Neoplasm Metastasis (Metastasis)
03/2016
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2015
1
Residual Neoplasm
08/2012
1
Triple Negative Breast Neoplasms
08/2012
1
Prostatic Neoplasms (Prostate Cancer)
08/2003
1
Anemia
08/2003
Drug/Important Bio-Agent (IBA)
2
Biomarkers (Surrogate Marker)
IBA
01/2023 - 01/2019
2
DNA (Deoxyribonucleic Acid)
IBA
01/2020 - 08/2012
1
pembrolizumab
IBA
04/2024
1
Immune Checkpoint Inhibitors
IBA
04/2024
1
human ERBB2 protein
IBA
01/2023
1
Ado-Trastuzumab Emtansine
IBA
01/2023
1
Immunoconjugates (Immunoconjugate)
IBA
01/2023
1
Biosimilar Pharmaceuticals
IBA
01/2018
1
Proteins (Proteins, Gene)
FDA Link
03/2016
1
N-acetyltalosaminuronic acid (NAT)
IBA
01/2016
1
Prednisolone (Predate)
FDA Link
Generic
04/2015
1
Cetuximab (Erbitux)
FDA Link
01/2014
1
Paraffin
IBA
08/2012
1
Formaldehyde (Formol)
FDA Link
08/2012
1
Endothelin Receptor Antagonists
IBA
08/2003
1
Endothelins (Endothelin)
IBA
08/2003
1
Atrasentan
IBA
08/2003
1
Hormones (Hormone)
IBA
08/2003
1
matrigel
IBA
09/2002
1
Hemoglobins (Hemoglobin)
IBA
09/2002
1
Platelet Endothelial Cell Adhesion Molecule-1
IBA
09/2002
Therapy/Procedure
8
Therapeutics
04/2024 - 08/2003
3
Immunotherapy
01/2019 - 01/2016
2
Precision Medicine
01/2020 - 01/2020
1
Radiotherapy
01/2014
1
Drug Therapy (Chemotherapy)
01/2014
1
Aftercare (After-Treatment)
08/2012
1
Adjuvant Chemotherapy
12/2007
1
Hemodilution
08/2003